Navigation and service

You are here:Risk Assessment Procedures

Medicinal products containing hydroxyethyl starch (HES): Standing Committee refers procedure back to European Medicines Agency (EMA)

Date 2018.04.12
Active substance hydroxyethyl starch

The BfArM issues information on the opinion of the Standing Committee for Medicinal Products for Human Use regarding HES within the European safety review in accordance with Article 107i of Directive 2001/83/EC for medicinal products containing HES

For details on the procedure please click on the following link to the homepage of the European Medicines Agency (EMA):

EMA starts new review of hydroxyethyl-starch containing medicines